Reviva Pharmaceuticals Holdings

RVPH36

Penny Stock

$1.27arrow_drop_up12.44%$0.13

Penny Stock

RVPH36

$1.27

arrow_drop_up12.44%$0.13

Penny Stock

Performance History

Key Stats
Open	$1.13
Prev. Close	$1.12
EPS	-1.32
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$37.62M
PE Ratio	-

	LOW	HIGH
Day Range	1.08	1.21
52 Week Range	0.60	6.80

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-1.32

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Reviva Pharmaceuticals Holdings (RVPH)

Reviva Pharmaceuticals Holdings, Inc. (RVPH) is a pharmaceutical company focused on developing and commercializing innovative therapeutics for diseases with unmet medical needs. With a mission to improve patients' quality of life, Reviva Pharmaceuticals Holdings is committed to discovering and developing novel drugs that target specific molecular pathways.

As of the latest trading session, the stock price of Reviva Pharmaceuticals Holdings, Inc. (RVPH) stands at [insert current stock price here]. The stock has had a volatile history, experiencing fluctuations in response to market dynamics and company-specific developments. Investors should carefully consider the inherent risks associated with investing in biotechnology companies.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Laxminarayan Bhat Ph.D.
Headquarters: Cupertino
Employees: 10
Exchange: NASDAQ

add Reviva Pharmaceuticals Holdings to watchlist

Keep an eye on Reviva Pharmaceuticals Holdings

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Reviva Pharmaceuticals Holdings's (RVPH) price per share?

The current price per share for Reviva Pharmaceuticals Holdings (RVPH) is $1.27. The stock has seen a price change of $0.14 recently, indicating a 12.44% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Reviva Pharmaceuticals Holdings (RVPH)?

For Reviva Pharmaceuticals Holdings (RVPH), the 52-week high is $6.8, which is 435.43% from the current price. The 52-week low is $0.6, the current price is 111.67% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Reviva Pharmaceuticals Holdings (RVPH) a growth stock?

Reviva Pharmaceuticals Holdings (RVPH) has shown an average price growth of -6.8% over the past three years. It has received a score of 28 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Reviva Pharmaceuticals Holdings as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Reviva Pharmaceuticals Holdings (RVPH) stock price performance year to date (YTD)?

As of the latest data, Reviva Pharmaceuticals Holdings (RVPH) has a year-to-date price change of -76.08%. Over the past month, the stock has experienced a price change of -0.78%. Over the last three months, the change has been 58.75%. Over the past six months, the figure is -23.95%.

help

Is Reviva Pharmaceuticals Holdings (RVPH) a profitable company?

Reviva Pharmaceuticals Holdings (RVPH) has a net income of -$39.26M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$39.5M. Furthermore, the EBITDA is $0.

help

What is the market capitalization of Reviva Pharmaceuticals Holdings (RVPH)?

Reviva Pharmaceuticals Holdings (RVPH) has a market capitalization of $42.47M. The average daily trading volume is 1.24, indicating the stock's liquidity and investor engagement.